GT Biopharma Inc Stock Performance
as on May 8, 2026 at 5:12 am IST
Day's High
$0.39$0.415.13%
Upside
52 Week's Low
52 Week's High
$0.26$3.85
33.08%
Downside
887.18%
Upside
GT Biopharma Inc share price movements today
- Previous Close
- $0.40
- Open
- $0.41
- Volume
- 778.9K
- Day's Low - High
- $0.39 - $0.41
- 52 Week Low - High
- $0.26 - $3.85
GT Biopharma Inc Historical Returns
- 1 Month Return
- -2.56 %
- 3 Month Return
- -25.27 %
- 1 Year Return
- -83.04 %
- 3 Year Return
- -95.52 %
- 5 Year Return
- -99.92 %
GT Biopharma Inc Stock Fundamentals & Key Indicators
Check GT Biopharma Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$13.5M
EPS (TTM)
-0.32
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
1.0494
EBITDA
-6.8M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-1377.41%
GT Biopharma Inc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of GT Biopharma Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $13.5M | -99.92% | NA | 0.00% | |
| BUY | $40.5B | 130.77% | 76.32 | 12.55% | |
| NA | $32.5B | NA | 70.89 | 5.37% | |
| BUY | $108.5B | 98.9% | 25.38 | 35.51% | |
| BUY | $75.6B | 45.15% | 17.6 | 29.65% |
Stock Returns calculator for GT Biopharma Inc Stock including INR - Dollar returns
The GT Biopharma Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
GT Biopharma Inc investment value today
Current value as on today
₹18,228
Returns
Returns from GT Biopharma Inc Stock
Dollar Impact
₹1,841 (+1.84%)
Analyst Recommendation on GT Biopharma Inc Stock
Based on 7 analysts
85.71%
Buy
14.29%
Hold
0.00%
Sell
Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for GT Biopharma Inc. Average target price of $3
GT Biopharma Inc Share Price Target
Get share price movements and forecasts by analysts on GT Biopharma Inc.
What analysts predicted
87%UPSIDE
Target Price
$3
Current Price
$0.39
Analyzed by
7 Analysts
Target
$3.00
GT Biopharma Inc target price $3, a slight upside of 87% compared to current price of $0.39. According to 7 analysts rating.
Indian Investors' Interest in GT Biopharma Inc Stock
Search interest for GT Biopharma Inc Stock has increased by 47% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:47% versus previous 30 day period
GT Biopharma Inc Quarterly Profit & Loss
All numbers in Millions USD
GT Biopharma Inc Annual Profit & Loss
All numbers in Millions USD
GT Biopharma Inc Quarterly Cash Flow
All numbers in Millions USD
GT Biopharma Inc Annual Cash Flow
All numbers in Millions USD
Insights on GT Biopharma Inc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 7 days, GTBP stock has moved up by 30.7%
NO EFFECTAgainst Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 25.4% return, outperforming this stock by 120.9%
- NO EFFECT
Against Peers
In the last 1 year, BeOne Medicines Ltd has given 34.9% return, outperforming this stock by 117.9%
About GT Biopharma Inc
| Organisation | GT Biopharma Inc |
| Headquarters | 315 Montgomery Street, San Francisco, CA, United States, 94104 |
| Industry | Biotechnology |
| CEO | Mr. Michael Martin Breen L.L.B. |
| E-voting on shares | Click here to vote |
Key Management of GT Biopharma Inc
Name | Title |
|---|---|
Mr. Michael Martin Breen L.L.B. | President, CEO & Executive Chairman |
Mr. Alan Louis Urban CPA | CFO & Secretary |
FAQs
What is GT Biopharma Inc share price today?
GT Biopharma Inc share price today is $0.39 as on . GT Biopharma Inc share today touched a day high of $0.41 and a low of $0.39.
What is the 52 week high and 52 week low for GT Biopharma Inc share?
GT Biopharma Inc share touched a 52 week high of $3.85 on and a 52 week low of $0.26 on . GT Biopharma Inc stock price today i.e. is trending at $0.39,which is 89.87% down from its 52 week high and 49.43% up from its 52 week low.
What is GT Biopharma Inc's market capitalisation today?
GT Biopharma Inc market capitalisation is $0.00T as on .
How to invest in GT Biopharma Inc Stock (GTBP) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for GT Biopharma Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in GT Biopharma Inc Shares that will get you 3.8462 shares as per GT Biopharma Inc share price of $0.39 per share as on May 7, 2026 at 11:42 pm IST.
What is the minimum amount required to buy GT Biopharma Inc Stock (GTBP) from India?
Indian investors can start investing in GT Biopharma Inc (GTBP) shares with as little as ₹94.24 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹942.40 in GT Biopharma Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on GT Biopharma Inc share’s latest price of $0.39 as on May 7, 2026 at 11:42 pm IST, you will get 25.6410 shares of GT Biopharma Inc. Learn more about
fractional shares .
What are the returns that GT Biopharma Inc has given to Indian investors in the last 5 years?
GT Biopharma Inc stock has given -99.92% share price returns and 29.81% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?